Evaluation of Efficacy of ALK Inhibitors According to Body Mass Index in ALK Rearranged NSCLC Patients—A Retrospective Observational Study

por Siringo, Marco, Gentile, Gabriella, Caponnetto, Salvatore, Sperduti, Isabella, Santini, Daniele, Cortesi, Enrico, Gelibter, Alain Jonathan
Publicado 2023

Combination Therapy in Renal Cell Carcinoma: the Best Choice for Every Patient?

por Rossi, Ernesto, Bersanelli, Melissa, Gelibter, Alain Jonathan, Borsellino, Nicolò, Caserta, Claudia, Doni, Laura, Maruzzo, Marco, Mosca, Alessandra, Pisano, Carmela, Verzoni, Elena, Zucali, Paolo Andrea
Publicado 2021

Evaluation of Drug—Drug Interactions in EGFR-Mutated Non-Small-Cell Lung Cancer Patients during Treatment with Tyrosine-Kinase Inhibitors

por Occhipinti, Mario, Brambilla, Marta, Galli, Giulia, Manglaviti, Sara, Giammaruco, Maristella, Prelaj, Arsela, Ferrara, Roberto, De Toma, Alessandro, Proto, Claudia, Beninato, Teresa, Zattarin, Emma, Lo Russo, Giuseppe, Gelibter, Alain Jonathan, Simmaco, Maurizio, Preissner, Robert, Garassino, Marina Chiara, De Braud, Filippo, Marchetti, Paolo
Publicado 2021